Physician profile
Bernard A Arnold
NPI 1235155292
$4,992.24
in general payments reported to CMS, 2019-2025
18 companies · $801 in 2025
The $801 reported for 2025 was more than what 87% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $463 · 2020: $162 · 2021: $416 · 2022: $1,162 · 2023: $879 · 2024: $1,110 · 2025: $801.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,573 · Entertainment: $217.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,573.29 |
| Entertainment | $217.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $950.93 | 2019-2025 | Total30, Tryptyr |
| Sun Pharmaceutical Industries INC. | $496.55 | 2022-2025 | Cequa |
| Abbvie INC. | $394.02 | 2022-2024 | Vuity |
| Bausch & Lomb Americas INC. | $370.90 | 2022-2025 | Infuse |
| Optos, INC. | $319.30 | 2019-2024 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Allergan, INC. | $305.20 | 2020-2022 | |
| Coopervision INC. | $304.90 | 2023-2025 | Misight Contact Lens, Myday Contact Lens |
| Oyster Point Pharma, INC. | $285.14 | 2022-2024 | Tyrvaya |
| Horizon Therapeutics Plc | $249.79 | 2022-2023 | Tepezza |
| Tarsus Pharmaceuticals, INC. | $242.42 | 2024-2025 | Xdemvy |
| Johnson & Johnson Vision Care, INC. | $218.49 | 2019-2023 | Acuvue |
| Sight Sciences, INC. | $209.55 | 2023-2024 | Omni Surgical System |
| Biotissue Holdings INC. | $145.75 | 2022 | |
| Maculogix, INC. | $126.33 | 2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $125.00 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $111.74 | 2025 | Acthar |
| Rxsight INC | $78.95 | 2025 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens |
| Dompe US, INC. | $57.28 | 2025 | Oxervate |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bernard Arnold listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.